Discontinuation report TYPHIM VI
| Report ID | 136117 |
| Drug Identification Number | 02130955 |
| Brand name | TYPHIM VI |
| Common or Proper name | Salmonella typhi Vi Capsular Polysaccharide Vaccine |
| Company Name | SANOFI PASTEUR LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE |
| Strength(s) | 25MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
| Packaging size | 10 mL multidose vial (20 Doses) |
| ATC code | J07AP |
| ATC description | BACTERIAL VACCINES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-04-01 |
| Actual discontinuation date | 2021-04-01 |
| Remaining supply date | 2021-04-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Sanofi Pasteur will be discontinuing the multidose vial presentation of Typhim Vi ® vaccine effective April 1st 2021. The single dose syringe presentation of Typhim Vi® will still be available to the market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
| Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-03-23 | English | Compare |
| v2 | 2021-03-23 | French | Compare |
| v3 | 2021-04-02 | English | Compare |
Showing 1 to 3 of 3